Europe
Allianz German Business Unit Eyes Growth While Exploring Merger Opportunities
Allianz has been in the focus of its own growth in the German market. The business unit of Allianz in Germany has been considering merger opportunities in the Germany market as it focuses on increasing its business presence, according to Markus Riess, unit head.
Sorin Group Finalizes Additional Investment in Enopace Biomedical
Sorin Group and Enopace Biomedical have reached agreement in which the former is provided with the power to acquire the latter in the future.
Bayer Predicts Peak Annual Sales for Xarelto
Bayer AG is predicting that its Xarelto, a drug to prevent stroke, will reach peak annual sales. Bayer AG said it expects Xarelto, its new promising drug for treating and preventing stroke, to reach peak annual sales at the end of the decade, company's chief executive Marijin Dekker said in a statement.
TNK-BP Reports 13% Drop in 2012 Net Profit
TNK-BP has posted 13% decline in net profit for the year 2012 after it agreed to be acquired by Russia's oil producer Rosneft.